MedTrace Logo

High Flow Nasal Cannula Use in Infants With Bronchiolitis

NCT02737280 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2018-12-19

No results posted yet for this study

Summary

Infants with viral bronchiolitis are currently treated with oxygen therapy if oxygen saturation is low. In earlier observational clinical studies, the use of high flow nasal cannulae therapy in infants with bronchiolitis has been associated with a decreased rate of intubation and intensive care. This study is a randomized controlled trial in two pediatric university hospitals in Finland comparing high flow nasal cannulae therapy to usual oxygen therapy in infants with bronchiolitis.

Conditions

  • Bronchiolitis

Interventions

DEVICE

Airvo (TM, Fisher & Paykel Healthcare) - High flow oxygen therapy

High flow nasal cannula therapy with Airvo (TM, Fisher \& Paykel Healthcare) device

DEVICE

MedKit Finland - Usual oxygen therapy

Oxygen therapy with normal nasal cannula (for example MedKit Finland) 0-2 l/min

Sponsors & Collaborators

  • University of Oulu

    lead OTHER

Principal Investigators

  • Marjo Renko, MD, PhD · University of Oulu

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02737280 on ClinicalTrials.gov